Literature DB >> 12526176

Lentiviral vectors for gene transfer to the central nervous system. Applications in lysosomal storage disease animal models.

Deborah J Watson1, John H Wolfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12526176     DOI： 10.1385/1-59259-304-6:383

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  10 in total

1.  Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis.

Authors:  C H Vite; S Magnitsky; D Aleman; P O'Donnell; K Cullen; W Ding; S Pickup; J H Wolfe; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

Review 2.  Progress in gene therapy for neurological disorders.

Authors:  Michele Simonato; Jean Bennett; Nicholas M Boulis; Maria G Castro; David J Fink; William F Goins; Steven J Gray; Pedro R Lowenstein; Luk H Vandenberghe; Thomas J Wilson; John H Wolfe; Joseph C Glorioso
Journal:  Nat Rev Neurol       Date:  2013-04-23       Impact factor: 42.937

3.  Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes.

Authors:  Mausam Ghosh; Yongjie Yang; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

4.  Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.

Authors:  E Aguilar Salegio; A P Kells; R M Richardson; P Hadaczek; J Forsayeth; J Bringas; S P Sardi; M A Passini; L S Shihabuddin; S H Cheng; M S Fiandaca; K S Bankiewicz
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 5.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

6.  Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.

Authors:  Marco A Passini; Deborah J Watson; Charles H Vite; Daniel J Landsburg; Alyson L Feigenbaum; John H Wolfe
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.

Authors:  Ernesto A Salegio; Lluis Samaranch; Russell W Jenkins; Christopher J Clarke; Clementine Lamarre; Janine Beyer; Adrian P Kells; John Bringas; Waldy San Sebastian; R Mark Richardson; Kate H Rosenbluth; Yusuf A Hannun; Krystof S Bankiewicz; John Forsayeth
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

8.  Identification of the rostral migratory stream in the canine and feline brain.

Authors:  Saafan Z Malik; Melissa Lewis; Alison Isaacs; Mark Haskins; Thomas Van Winkle; Charles H Vite; Deborah J Watson
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.

Authors:  Wenpei Liu; Gerald Griffin; Trena Clarke; Michael K Parente; Rita J Valentino; John H Wolfe; Nigel W Fraser
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-28       Impact factor: 6.698

Review 10.  Animal models for target diseases in gene therapy--using DNA and siRNA delivery strategies.

Authors:  Ian S Blagbrough; Chiara Zara
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.